Since its IPO last June, dLocal (NASDAQ: DLO) has enjoyed an impressive year on many fronts. In this video clip from the "Future of Fintech" on Motley Fool...
Pfizer’s promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030. Lilly’s got a drug in development, too.
Read More...
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Read More...
Outside the Box: 3 ways Russia’s war in Ukraine could end — and even a Ukraine victory brings danger
Depending on how long the war continues, the economic impact could be even worse for the developing world than the 2008 financial crisis.
Read More...
We asked sleep coaches and experts to share their favorite cooling comforters and duvets.
Read More...
Money and investing stories popular with MarketWatch readers over the past week.
Read More...
Snap's stock dropped by more than 40% after the company hinted that headwinds worsened in the last month. Read More...
Year to date, Alphabet is down nearly 27%, based on fears of a cyclical slowdown in advertising dollars. With pessimism now being extrapolated across the...
With inflation sky high and the Federal Reserve tightening monetary policy in response, 2022 is sure to be one of the more volatile years for the stock market...
Amazon's stock split will take place on June 3 and you'll end up with more shares in your account if you qualify. Read More...
